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Background: The government has recognised the role of healthcare professionals in smoking cessation
interventions with integrated care pathways for identification and referral of at-risk patients who smoke. Referral for
suspected cancers has been suggested as a ‘teachable moment’, whereby individuals are motivated and more likely
to adopt risk-reducing behaviours. A head and neck cancer referral clinic could therefore provide opportunities for
smoking cessation intervention.
This study aims to pilot a brief smoking cessation intervention during a consultation visit for patients referred with
suspected head and neck cancer and evaluate its acceptability and impact.
Methods: A brief script for smoking cessation intervention which included a smoking cessation referral was
designed to be delivered to patients attending a rapid access clinic. Patient outcome data was collected by the
stop smoking team for patients who accepted the referral. A subset of these patients was also interviewed by
telephone; these findings were combined with data provided by the stop smoking services to assess the
acceptability and impact of pilot smoking cessation intervention on patients.
Results: In total, 473 new patients attended the clinic during the study period, of whom 102 (22%) were smokers.
Of these, 80 (78%) accepted a referral to stop smoking services. A total of 75 (74%) patients were approached
subsequently in a telephone survey. Of the 80 newly referred patients, 29 (36%) quit smoking at least temporarily.
Another eight patients reduced their smoking or set a quit date (10%), so the experience of attending the clinic
and the intervention impacted favourably on almost half of the patients (46%). The patient survey found the
intervention to be acceptable for 94% (n = 50) of patients. Qualitative analysis of patient responses revealed five
elements which support the acceptability of the intervention.
Conclusions: The findings of this pilot study suggest that discussion of smoking cessation with patients referred for
suspected head and neck cancer may have an impact and facilitate the process towards quitting. A possible
diagnosis of cancer appears to present a ‘teachable moment’ to encourage positive health behaviour change.
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Cancers in the head and neck region account for about 3%
of all cancers diagnosed in England [1]. The incidence of
head and neck cancer nationally and in south east London
is increasing [2].
The majority of head and neck cancers are squamous
cell carcinomas and the main risk factors are tobacco* Correspondence: mingwei.tang@nhs.net
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unless otherwise stated.smoking, alcohol consumption, and human papilloma
virus infection. In a large international study, tobacco
and alcohol together explained 73% of upper aero-
digestive tract (UADT) cancer burden, of which almost
29% was due to tobacco alone, less than 1% alcohol
alone and 44% by the joint effect of tobacco and alcohol
[3]. Smoking was an independent risk factor for head
and neck cancer while alcohol consumption in the ab-
sence of smoking conferred little or no risk. The joint ef-
fect of tobacco and alcohol increased with the number
of pack-years and drink-years [4]. Tobacco smoking ishis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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and reducing smoking prevalence is one of three key
commitments at the heart of the NHS cancer plan [5].
The government has commissioned several white pa-
pers [6-9], which provide guidance for tobacco control
policy in England. These documents highlight the im-
portant role of healthcare professionals in smoking ces-
sation. It is within their capacity to proactively discuss
the issue of smoking with patients as it is linked to im-
proved general health. Integrated care pathways must be
developed and utilised for identification and referral of
at-risk patients who smoke. The NHS stop smoking ser-
vice plays a key role within this care pathway. Studies
have shown that smokers accessing this service are four
times more likely to achieve a four-week quit than those
without this assistance [10]. Godfrey et al., found NHS
smoking cessation services to be a cost-effective life-
saving intervention when compared to many other
health-care interventions [11]. Although not ideal, there
is evidence that cutting down smoking can be an im-
portant part of the process of stopping [12,13].
The importance of making every contact count for
health has been emphasised in recent health policy [14].
Patients referred via the two week wait route are perceived
by the GP as being at high risk of cancer and early inter-
vention will potentially improve their outcome. With the
increasing incidence of head and neck cancer, the initial
thrust to pilot a disease prevention program stemmed
from the South East London Tumour Working Group.
The impact of a smoking cessation intervention is plaus-
ibly translatable to patients at risk of other smoking re-
lated illnesses.
Events such as attending a head and neck cancer diag-
nosis service have been suggested to be a ‘teachable mo-
ment’ whereby individuals may become motivated to
adopt risk-reducing behaviours. Several studies have
shown high rates of smoking cessation amongst patients
with newly diagnosed head and neck cancer [15,16]. This
finding may be explained using the health belief model
whereby patients perceive a susceptibility to head and
neck cancer and its threat, which may be a ‘cue to action’
because the benefit of quitting smoking is evident [17].
A teachable moment in the health care setting may
be exploited to encourage smoking cessation in pa-
tients with suspected head and neck cancer [18]. The
initial diagnostic clinic provides such an opportunity
for healthcare professionals to help modify patient be-
haviour by giving smoking cessation advice and direct-
ing patients towards existing smoking cessation
services. Valid concerns about such an intervention in-
clude whether the intervention is effective in contribut-
ing to smoking cessation, and whether the intervention
may be unduly stressful at a moment of anxiety and
concern [19].The aims of this study were to assess the acceptability,
and impact, of a brief smoking cessation intervention dur-
ing the first consultation visit for patients referred with
suspected head and neck cancer with a view to informing
health policy and action.
Methods
The intervention
The study population consisted of all patients who were
referred to and attended the head and neck cancer clinic
(Mr R Oakley; RO) in 2012 at Guy’s and St Thomas’
NHS Foundation Trust. During the patient’s first consult-
ation visit, RO followed a scripted intervention which was
evidence based [20], developed jointly with the stop-
smoking co-ordinator (See ‘Intervention protocol’). Pa-
tients who were smokers were offered the opportunity to
be referred to their local stop smoking team.
Intervention protocol
Q: Is there anything you do that may have contributed
to the symptoms you have come to see me about today?
If they do not mention smoking:
Q: Do you think smoking may have contributed to your
symptoms? Following the response, go on to explain that
there is a link.
Q: Have you thought about giving up? I know that it’s
not easy to quit smoking so I’d like to refer you to some-
one who can tell you about what services there are avail-
able to help people quit smoking. You can then decide if
this help seems likely to work for you. Are you happy to
receive this phone call? If a patient accepts the referral
they will be referred via EPR, and given a copy of a letter
confirming the referral.
If the patient declined the referral this was noted and
the patient was given an information leaflet about NHS
smoking cessation services to take with them.
All referrals were collated by the hospitals stop-smoking
coordinator and passed to the appropriate local commu-
nity team for the patient’s home address.
Data collection
Stop smoking team
The stop smoking team collected data on the outcome
of all patients contacted by the team; whether they have
made local arrangements to achieve smoking cessation,
already quit, accepted or rejected the service.
Personal interviews
A survey instrument was designed by the authors to as-
sess patients’ thoughts and opinion on the suitability of
the brief smoking cessation intervention during the con-
sultation visit. The questionnaire also included questions
on patients’ smoking status. Patients were considered eli-
gible for the post-intervention survey study if they had
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cessation referral and were able to communicate effect-
ively in English.
Eligible patients were sent a letter to inform them of
the research group’s intent to undertake a telephone sur-
vey and the method of opting out. Patients who did not
opt out were contacted by telephone (MW Tang) at least
4 months after the initial consultation appointment. A
verbal consent was obtained prior to the interview and
patient responses were recorded on a paper survey form
by the interviewer. All interviews were conducted by
one interviewer to ensure consistency of approach.
Data analysis
Quantitative results from the telephone survey were linked
with the smoking cessation outcome data collected by the
stop smoking team. Both sets of data were cross checked
for consistency in patient reported outcomes. Outcomes
of intervention were divided into four categories:
1. Quit (patients who successfully quit after the
intervention regardless of time period);
2. Action (patients who took action in view of quitting
eg. set quit date);
3. Motivation (patients who want to quit);
4. Null (patients who could not be contacted or none
of the above).
Data were tabulated in a Microsoft Excel spreadsheet
and analysed accordingly. The qualitative data were ana-
lysed by looking at themes and patterns using inductive
reasoning [21]. Descriptive analysis was conducted on
the combined data sets to allow a better understanding
of the impact of intervention on patient outcome and its
acceptability.
Approval for this service evaluation was obtained from




A total of 473 patients were seen in the head and neck
cancer clinic during the period of study (Figure 1). Of
these, 102 (22%) were smokers. Six of the smokers were
already attending smoking cessation support and 80 ac-
cepted a new referral to the Stop Smoking Service. No
offer was made to eight patients as it was deemed in-
appropriate and eight declined a referral.
Of the 80 referred patients, 47 (59%) were male and 33
(41%) were female and they covered six decades in age.
The 80 new referrals resulted in 29 (36%) patients quitting
smoking at least temporarily. Another eight patients re-
duced their smoking or set a quit date (10%), so the experi-
ence of attending the clinic and the intervention impactedfavourably on almost half of the patients (46%). Distribu-
tion of patient sex, age and ethnicity of patients referred in
relation to smoking cessation outcome can be found in
Figures 2, 3 and 4. Apart from the extremes of age, there
was some evidence of positive change across all groups.
Ten out of the 11 patients with a positive diagnosis in this
sample provided evidence of quitting.
Personal interviews
In total, 75 patients were deemed suitable for telephone
interview and 57 (76%) were successfully contacted for
the telephone survey. Of these 53 (93%) were suitable
for completion of the questionnaire. The majority of the
respondents (50 out of 53 patients; 94%) were content
that the issue of smoking was discussed with the surgeon
during their initial consultation visit (Figure 5). Almost
three quarters of respondents (n = 39; 74%) reported that
the appointment at the head and neck clinic had made a
difference as to how they felt about smoking. For some
(n = 14; 26%), this was enough to make them quit. When
asked whether the discussion about smoking at the ini-
tial visit (intervention) influenced their decision to stop
smoking, a minority (n = 19; 36%) answered in the negative
or were unsure. Four patients (7.5%) further commented
that it was the illness itself rather than the intervention that
was influential. A small proportion (n = 6; 11%) of patients
interviewed indicated that they had no intention to stop
smoking.
Qualitative analysis
There were five elements to the reported satisfaction or
dissatisfaction with the intervention:
1. Nature of the intervention: Patients felt that the
intervention gave them important information and
raised awareness about the link between smoking
and head and neck cancer. It was also appropriate
and relevant to why they were at the appointment.
Some however lamented the repetitive nature of
intervention as the same message is repeated in
various media and settings.
2. Who delivered the intervention: Patients highlighted
that RO’s position as a consultant surgeon gave him
authority as a specialist expert in the field with
extensive knowledge and experience with head and
neck cancer. Ultimately however, ‘only the smoker
can decide’ whether or not to take up the advice.
3. Timing of the intervention: Views were divided on
whether the timing of the intervention was
appropriate. Some patients felt the advice was
reassuring and worked as a cue to stop smoking.
Other patients felt that it was ‘too much to digest’ in
one short appointment, and one patient felt that the
consultation ‘was hijacked’ to discuss smoking
Figure 1 Flow chart for outcome of smoking cessation intervention.
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head and neck cancer felt that the intervention came
too late.
4. Place of the intervention: Patients unanimously
agreed that the hospital setting is the right place to
discuss smoking cessation.
5. How the intervention was delivered: Views were
divided on whether the method of intervention was
appropriate. Patients appreciated the direct and
caring nature of RO when delivering the
intervention. A minority view, however, was unsure
whether the ‘scare tactic’ or ‘shock tactic’ was
appropriate. One commented that he felt that the
intervention was ‘premeditated and manipulative’ of
the patient’s emotions.Figure 2 Outcome of accepted smoking cessation referrals by sex (sourDiscussion
The script for intervention in this study was modified
from the guidelines on smoking cessation for health
professionals [20], published in the British Medical
Journal. This brief intervention is divided into four
stages: 1. Ask – about smoking status; 2. Advise – all
smokers to stop; 3. Assist – the smoker to stop; 4. Ar-
range – follow up on smoking status or refer for fur-
ther help. It is not feasible to follow up smokers who
reject a smoking cessation referral in a secondary care
setting. In this protocol, all patients who declined a
smoking cessation referral were given an information
leaflet on NHS smoking cessation services so they
could access it independently should they change
their mind.ce: data combined from patient survey and stop smoking team).
Figure 3 Outcome of accepted smoking cessation referrals by age (Source: Data combined from patient survey and stop smoking team).
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process rather than a distinct event [22]. Various psycho-
logical models describe the process as non-linear, as pa-
tients move forwards and backwards in the process of
change. The stop smoking teams use ‘four week quit’ as a
measure of successful smoking cessation. Although this is
an arbitrary period, it is useful for measuring outcomes
and key performance indicators. In reality, however, most
patients quit ‘temporarily’ in the process of change. We
therefore made a decision to consider any successful at-
tempts at quitting regardless of time period a positive
outcome.
The brief smoking cessation intervention aims to steer
patients towards positive behaviour change, which was suc-
cessful in 46% of patients in this cohort (n = 37). A furtherFigure 4 Outcome of accepted smoking cessation referrals by ethnicity (18% (n = 14) of patients were motivated to quit smoking
after the appointment. Overall, the findings suggest that the
brief intervention made a positive impact on 64% of 80
smokers who accepted a referral to stop smoking team.
Of the 29 patients who quit following the appoint-
ment, only 15 (52%) were successfully contacted by the
stop smoking team and of these, only seven accepted the
service. The brief discussion during the consultation visit
was sufficient to support behaviour change for a majority
of these patients. The level of cessation related to the
head and neck cancer clinic exceeds that for brief sim-
ple advice about smoking cessation by medical practi-
tioners [23]. It is likely that the possibility or diagnosis
of head and neck cancer had a large influence on pa-
tients’ decision to stop smoking. Out of 11 patients whosource: data combined from patient survey and stop smoking team).
Figure 5 Flow chart of patient reported outcomes from telephone interview.
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(91%) quit smoking after the appointment. Although
the level of change was higher amongst patients with a
positive diagnosis, more of the patients with evidence of
positive behaviour change did not have a positive diag-
nosis at that time.
Despite the overall positive feedback from patients
and favourable outcome from the brief intervention,
there is still a small group of patients who are resistant
to behaviour change. These patients benefit little from
smoking cessation advice, advertisements, cigarettepackaging regulations, and other tobacco control mea-
sures alone. They are aware of the risks of tobacco to
health but do not intend to adopt risk reducing behav-
iours due to other interplaying factors. In this group of
patients, combinations of tobacco control measures are
needed to encourage behaviour change. Smoking cessa-
tion has to be tackled through changes in legislation,
economy and culture, and supported by health services.
Further research into this group of ‘hard-to-reach’ pa-
tients can help develop future plans and guidance for
tobacco control.
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group and absence of information about spontaneous
smoking cessation and quitting. This was a pilot study
conducted within existing resources and further research
should include a control group. Another limitation was
the variable time interval between the brief intervention
and survey interview as patients were not recalled to the
clinic and had to be followed up by phone which was
subject to patient and researcher availability. This intro-
duces variation in recall and complicates the definition
of the outcomes. This was one of the reasons that any
attempt at quitting was considered a positive outcome in
this analysis, together with the evidence supporting the
recognised importance of ‘reduce to quit’ [12,13] in to-
bacco cessation. Furthermore, patients reported smoking
status and quitting could not be validated by urine cotin-
ine levels or carbon monoxide concentrations in expired
air [24,25] as further clinical contact at the hospital was
not part of their routine care for all patients and this ini-
tiative was not resourced for follow up at home. The re-
sults from this service evaluation have been presented at
King’s Health Partners Cancer Centre biannual research
day. Findings of this study are helping to shape policy
and inform action on tobacco cessation. This intervention
is brief, cheap and evidence-based. Its implementation can
be immediate with no need for additional funding. As part
of a contemporary health policy, its effects are far reaching
beyond the benefits of head and neck cancer prevention in
supporting a common risk factor approach.
Conclusion
The brief smoking cessation intervention during a con-
sultation visit regarding suspected head and neck cancer
is an opportunity for health promoting interventions.
Within the limitations of this pilot study, it has been
found to be effective and acceptable to the majority of
the patients surveyed. The prospect or diagnosis of head
and neck cancer has a large impact on a patient’s perspec-
tive on susceptibility to illness and therefore presents a
‘teachable moment’ where patients are more likely to be
motivated to modify behaviour.Ethics statement
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